1.Early port-site metastasis during neoadjuvant chemotherapy in advanced stage ovarian cancer: report of two cases.
Batuhan OZMEN ; Yavuz Emre SUKUR ; Cem Somer ATABEKOGLU ; Aylin Okcu HEPER ; Murat SONMEZER ; Mete GUNGOR
Journal of Gynecologic Oncology 2011;22(1):57-60
Port-site metastases in gynecological malignancies subsequent to laparoscopy have been reported with an incidence of 1.1-16%. These metastases tend to be disappearing after primary debulking surgery and subsequent primary chemotherapy. Local resection, chemotherapy and/or radiotherapy have been defined in the management of these metastases with enhanced clinical success. However, in extremely rare cases these metastases were also defined very early during neoadjuvant chemotherapy. Herein, we present two ovarian cancer cases which are clinically diagnosed with port site metastasis during neoadjuvant chemotherapy following diagnostic laparoscopy. Although neoadjuvant chemotherapy is sometimes needed in cases of fully advanced ovarian cancers, port-site metastasis may be encountered during neoadjuvant chemotherapy. The possible poor prognosis of these patients, especially those who have ascites, should make us careful in performing diagnostic laparoscopy with preventive measures for port-site metastasis and to start the chemotherapy immediately.
Ascites
;
Humans
;
Incidence
;
Laparoscopy
;
Neoplasm Metastasis
;
Ovarian Neoplasms
;
Prognosis
2.Incidentally Detected Cardiac Cyst Hydatid after Blunt Thoracic Trauma.
Ersan OZBUDAK ; Duygu DURMAZ ; Ali Ahmet ARIKAN ; Umit HALICI ; Sadan YAVUZ ; Ender EMRE
The Korean Journal of Thoracic and Cardiovascular Surgery 2014;47(2):160-162
Cardiac involvement in hydatid disease is more seldom than the involvement of the liver and the lungs. Cardiac cyst hydatid disease is diagnosed incidentally or by means of symptoms such as dyspnea and angina pectoris. Here, we present the case of a 45-year-old male patient who underwent open heart surgery for a randomly detected cardiac cyst hydatid during investigations carried out in a healthcare institution after accidentally falling from height. On the other hand, this patient did not have any complaints associated with hydatid disease before this event.
Angina Pectoris
;
Delivery of Health Care
;
Dyspnea
;
Hand
;
Humans
;
Liver
;
Lung
;
Male
;
Middle Aged
;
Thoracic Surgery
3.Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome
Bulut VARLI ; Yavuz Emre ŞÜKÜR ; Batuhan ÖZMEN ; Berrin İmge ERGÜDER ; Murat SÖNMEZER ; Bülent BERKER ; Cem ATABEKOĞLU ; Ruşen AYTAÇ
Clinical and Experimental Reproductive Medicine 2021;48(4):368-373
In this study we aimed to assess anorexigenic peptide levels in patients with or without polycystic ovary syndrome (PCOS) and their effects on assisted reproductive treatment (ART) outcomes. Methods: A prospective case-control study was conducted in a tertiary care university-based ART clinic. Eighty-three patients were included in the study. The PCOS group included 41 patients, and the non-PCOS group included 42 controls. The 2003 Rotterdam criteria were used for PCOS patient selection. The ART indications in the non-PCOS group were tubal factor or unexplained infertility. Venous blood samples were taken on the third day of the menstrual cycle to determine the serum anorexigenic peptide levels. The enzyme-linked immunosorbent assay method was used for laboratory analyses. Results: In the PCOS group, serum obestatin levels were significantly lower than in the control group, but serum anorexigenic peptide levels were similar in PCOS patients with or without clinical pregnancy. Ovarian hyperstimulation syndrome (OHSS) was diagnosed only in PCOS patients, and the obestatin levels of OHSS patients were significantly lower than those of other PCOS patients. Conclusion: Baseline anorexigenic peptide levels did not affect the clinical pregnancy rate in ART cycles. Obestatin may play a role in the pathophysiology of OHSS. This possibility should be confirmed in further research.
4.Dual trigger in normally-responding assisted reproductive technology patients increases the number of top-quality embryos
Yavuz Emre ŞÜKÜR ; Hasan ULUBAŞOĞLU ; Fatma Ceylan İLHAN ; Bülent BERKER ; Murat SÖNMEZER ; Cem Somer ATABEKOĞLU ; Ruşen AYTAÇ ; Batuhan ÖZMEN
Clinical and Experimental Reproductive Medicine 2020;47(4):300-305
Objective:
The feasibility of a gonadotropin-releasing hormone agonist (GnRHa) trigger in normal responders is still a matter of debate. The aim of this study was to compare the number of mature oocytes, the number of good-quality embryos, and the live birth rate in normal responders triggered by GnRHa alone, GnRHa and human chorionic gonadotropin (hCG; a dual trigger), and hCG alone.
Methods:
A retrospective cohort study was conducted at the infertility clinic of a university hospital. Data from 200 normal responders who underwent controlled ovarian hyperstimulation and intracytoplasmic sperm injection with a GnRH antagonist protocol between January 2016 and January 2017 were reviewed. The first study group consisted of patients with cycles triggered by GnRHa alone. The second study group consisted of patients with cycles triggered by both GnRHa and low-dose hCG (a dual trigger). The control group consisted of patients with cycles triggered by hCG alone.
Results:
The groups were comparable in terms of demographics and cycle characteristics. The numbers of total oocytes retrieved and metaphase II oocytes were similar between the groups. The total numbers of grade A embryos were 3.2±2.9 in the GnRHa group, 4.4±3.2 in the dual-trigger group, and 2.9±2.1 in the hCG group (p=0.014). The live birth rates were 21.4%, 30.5%, and 28.2% in those groups, respectively (p=0.126).
Conclusion
In normal responders, a dual-trigger approach appears superior to an hCG trigger alone with regard to the number of top-quality embryos produced. However, no clinical benefit was apparent in terms of live birth rates.
5.Lung ultrasonography in pregnant women during the COVID-19 pandemic: an interobserver agreement study among obstetricians
Murat YASSA ; Memis Ali MUTLU ; Pinar BIROL ; Taha Yusuf KUZAN ; Erkan KALAFAT ; Canberk USTA ; Emre YAVUZ ; Ilkhan KESKIN ; Niyazi TUG
Ultrasonography 2020;39(4):340-349
Purpose:
This study investigated interobserver agreement in lung ultrasonography (LUS) in pregnant women performed by obstetricians with different levels of expertise, with confirmation by an expert radiologist.
Methods:
This prospective study was conducted at a tertiary "Coronavirus Pandemic Hospital" in April 2020. Pregnant women suspected to have coronavirus disease 2019 (COVID-19) were included. Two blinded experienced obstetricians performed LUS on pregnant women separately and noted their scores for 14 lung zones. Following a theoretical and hands-on practical course, one experienced obstetrician, two novice obstetric residents, and an experienced radiologist blindly evaluated anonymized and randomized still images and videoclips retrospectively. Weighted Cohen's kappa and Krippendorff’s alpha tests were used to assess the interobserver agreement.
Results:
Fifty-two pregnant women were included, with confirmed COVID-19 diagnosis rate of 82.7%. In total, 336 eligible still images and 115 videoclips were included in the final analysis. The overall weighted Cohen’s kappa values ranged from 0.706 to 0.912 for the 14 lung zones. There were only seven instances of major disagreement (>1 point) in the evaluation of 14 lung zones of 52 patients (n=728). The overall agreement between the radiologist and obstetricians for the still images (Krippendorff's α=0.856, 95% confidence interval [CI], 0.797 to 0.915) and videoclips (Krippendorff's α=0.785; 95% CI, 0.709 to 0.861) was good.
Conclusion
The interobserver agreement between obstetricians with different levels of experience on still images and videoclips of LUS was good. Following a brief theoretical course, obstetricians' performance of LUS in pregnant women and interpretation of pre-acquired LUS images can be considered consistent.
6.Internalized Stigma in Pediatric Psoriasis: A Comparative Multicenter Study
Erkan ALPSOY ; Mualla POLAT ; Ibrahim Halil YAVUZ ; Pelin KARTAL ; Didem Didar BALCI ; Ayse Serap KARADAG ; Asli BILGIC ; Ercan ARCA ; Bilge Fettahlioglu KARAMAN ; Selma EMRE ; Esra ADISEN ; Neslihan SENDUR ; Ozlem BILGIC ; Ayca Cordan YAZICI ; Basak YALCIN ; Rafet KOCA ; Kamer GUNDUZ ; Murat BORLU ; Tulin ERGUN ; Pinar DURSUN ; Serap Gunes BILGILI ; Asli Surer ADANIR ; Ayla GULEKON ; Gizem YAGCIOGLU ; Ertan YILMAZ ; Ufuk KAVUZLU ; Yesim SENOL
Annals of Dermatology 2020;32(3):181-188
Background:
Internalized stigma, adoption of negative attitudes and stereotypes of the society regarding persons’ illness, has not been studied previously in pediatric psoriasis patients.
Objective:
We aimed to investigate the internalized stigma in pediatric psoriasis patients and to determine differences according to factors affecting internalized stigma compared to adult psoriasis patients.
Methods:
This multicenter,cross-sectional, comparative study included 125 pediatric (55 female, 70 male; mean age±standard deviation [SD], 14.59±2.87 years) and 1,235 adult psoriasis patients (577 female, 658 male; mean age±SD, 43.3±13.7 years). Psoriasis Internalized Stigma Scale (PISS), Dermatology Life Quality Index (DLQI), Perceived Health Status (PHS), and the General Health Questionnaire (GHQ)-12 were the scales used in the study.
Results:
The mean PISS was 58.48±14.9 in pediatric group. When PISS subscales of groups were compared, the pediatric group had significantly higher stigma resistance (p=0.01) whereas adult group had higher scores of alienation (p=0.01) and stereotype endorsement (p=0.04). There was a strong correlation between mean values of PISS and DLQI (r=0.423, p=0.001). High internalized stigma scores had no relation to either the severity or localization of disease in pediatric group. However, poor PHS (p=0.007) and low-income levels (p=0.03) in both groups, and body mass index (r=0.181, p=0.04) in the pediatric group were related to high PISS scores.
Conclusion
Internalized stigma in pediatric patients is as high as adults and is related to poor quality of life, general health, and psychological illnesses. Unlike adults, internalized stigma was mainly determined by psoriasis per se, rather than disease severity or involvement of visible body parts, genitalia or folds.